CMS Now Requires Compliance to Standards for Single-Dose Vials

CMS has issued a memorandum that states healthcare providers that do not comply with United States Pharmacopeia standards for single-dose vials are subject to federal citation, according to an AORN release.

Advertisement

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

USP standards 797 require that healthcare providers comply with strict rules for repackage and re-entering single dose. The standards include a requirement that healthcare providers use qualified, trained personnel to repackage single dose vials under International Organization for Standardization Class 5 air quality conditions within an ISO Class 7 buffer area. For a full overview of USP 797, click here.

Healthcare providers that fail to comply with these standards may be cited for deficiencies under applicable federal infection control standards.

Related Articles on Single Dose Vials:

Rep. Cliff Sterns Requests More Information on Single Dose Vials Guideline

Letter to the Editor: Clarifying Multiple-Dose Vial Usage

CDC Releases Statement Reiterating Position on Single Dose, Single Use Vials

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

Advertisement

Comments are closed.